Esperion Therapeutics, Inc. (ESPR)
3.69
-0.20
(-5.14%)
USD |
NASDAQ |
Dec 30, 16:00
3.71
+0.02
(+0.54%)
After-Hours: 20:00
Esperion Therapeutics Market Cap: 874.79M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 498.51B |
| Ovid Therapeutics, Inc. | 116.08M |
| NovaBay Pharmaceuticals, Inc. | 781.27M |
| Palatin Technologies, Inc. | 13.47M |
| Theriva Biologics, Inc. | 6.613M |
Market Cap Related Metrics
| PS Ratio | 2.399 |
| Price | 3.69 |
| Earnings Yield | -14.52% |